Trials / Completed
CompletedNCT04108676
Effect of Omeprazole on PK of Fluzoparib in Healthy Male Subjects
a Single-center, One-arm, Open, and Fixed Sequences Study to Evaluate the Effects of Omeprazole on the Pharmacokinetics of Fluzoparib in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the Effect of Omeprazole on the Pharmacokinetics of Fluzoparib in Healthy male Adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fluzoparib | PARP inhibitor |
| DRUG | Omeprazole | proton pump inhibitor |
Timeline
- Start date
- 2019-09-07
- Primary completion
- 2019-09-18
- Completion
- 2019-11-18
- First posted
- 2019-09-30
- Last updated
- 2022-07-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04108676. Inclusion in this directory is not an endorsement.